FindTrial
Sign In

Examination of efficacy of yokukansan for postoperative delirium.

Examination of efficacy of yokukansan for postoperative delirium. - Examination of efficacy of yokukansan for postoperative delirium.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000004417
Enrollment
200
Registered
2010-10-25
Start date
2010-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

yokukansan peroral administration, 7.5g/day, 3 times/day none

Sponsors

Nippon Medical School Musashi Kosugi Hospital
Lead Sponsor
Kanto Rosai hospital Kawasaki Saiwai hospital Teikyo University School Medicine Uniersity Hospital Mizonokuchi Omori Red Cross Hospital Kawasaki Municipal Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients over 75 years 2) There is no gender specification 3) Patients who have signed consent to participate in this research.

Exclusion criteria

Exclusion criteria: 1) Patients with malignancy, severe disease of heart, liver, renal, blood, lung and other life-threatening diseases 2) eurodegenerative disease, schizophrenia, bipolar disorder 3) Alcohol abuse, drug abuse 4) Patients who are otherwise classified as unfit by the attending physicians for the research.

Design outcomes

Primary

MeasureTime frame
CAM—

Countries

Japan

Contacts

Public ContactSatoshi Nomura

Nippon Medical School Musashi Kosugi Digestive Disease Center

carlos10valderrama@yahoo.co.jp044-733-5181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026